Skip to content

Ora Fiso

Active
Private limited companyfounded 2024active for 2 yearsMeerweg 22, 1980 Zemst, BelgiumKBO/BCE: BE 1005.247.523
Summary

Ora Fiso has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €169,997 and a net result of €92,904. Its solvency ranks better than 72% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 26-01-2024 Normal situation
Activity
Physiotherapy NACE 86951and 4 others
Establishment unit
2.354.914.926 1980 Zemst, since 26-01-2024
Financial year end
31 December
Peppol
Reachable since 18-03-2026

Board and ownership

Board

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€127,325
▲ 30.6%
Turnover
≈ €250,000
estimated
Profit
€92,904
▲ 28.9%
Equity
€169,997
▲ 121%
Total assets
€208,315
▲ 98.7%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 5.18, cash €117,801Equity €169,997 (81.6% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 84% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+1
equity 81.6% of total assets
Liquidity 95+5
short-term debt 18.4% · cash 56.5%
Profitability 100=
return on assets 44.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 02-2025: 0.3% 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.7%▲ +0.4 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.7 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €16,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 5.18 (3.74 in 2024), above the usual 1.5. Short-term debt is 18.4% and cash 56.5% of total assets. 18.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 82% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 5.18, cash €117,801
NBB · annual accounts
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Equity €169,997 (81.6% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-07-2026, 29 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
29 days early
2024
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 29 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Positive: Equity rose in 2025from €77,094 to €169,997 ▲ 121% View

Recent changes

  1. · Gazette deed Registered office moved from Mechelen to ZemstNew seat: Meerweg 22, 1980 Zemst · Previous seat: Spiegelstraat 6 bus 301, 2800 Mechelen
  2. · Gazette deed IncorporationAppointments: VAN DEN BROECK Thomas Hugo Freddy (director) and DUVERGER Marijke (director)
All 5 events

Comparable companies

These companies have the same main activity as Ora Fiso: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €177,000 and €249,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
Ora Fiso Zemst€208,315€127,325
KINE BONNEZ De Panne€196,554€131,520
USGN Médical Cerfontaine€185,359€131,757
Perfect-Balance Aarschot€249,295€124,781
PELVIK Tremelo€176,705€122,547
FysioFlow Dilbeek€179,900€119,688
PRAKTIJK ROBUUST Merchtem€200,525€133,219
Full comparison

Key facts about Ora Fiso

What is the company number of Ora Fiso?
The company number of Ora Fiso is 1005.247.523. The VAT number is the same number with BE in front: BE 1005.247.523.
Where is Ora Fiso based?
The registered office is at Meerweg 22, 1980 Zemst.Company details
What does Ora Fiso do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of Ora Fiso?
The legal form of Ora Fiso is Private limited company (BV).
When was Ora Fiso founded?
Ora Fiso was founded on 26-01-2024.
Is Ora Fiso still active?
Yes, Ora Fiso is an active enterprise in the KBO register.
What is the turnover of Ora Fiso?
The turnover in financial year 2025 is ≈ €250,000. This figure is estimated from the gross margin of €127,325 and 82 comparable companies (NACE 86). It probably lies between €190,000 and €320,000.Financials
Is Ora Fiso profitable?
In financial year 2025, Ora Fiso made a profit of €92,904.
Where can I find the annual accounts of Ora Fiso?
Ora Fiso filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Ora Fiso due?
Ora Fiso must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.